Nexalin Technology, Inc. Interest Expense
Nexalin Technology, Inc. (NXL) reported Interest Expense of -$129 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2026-08-12
- Nexalin Technology, Inc. interest expense for the quarter ending 2026-06-30 was -$129.00.
- Nexalin Technology, Inc. interest expense for the quarter ending 2026-03-31 was -$34.00.
- Nexalin Technology, Inc. interest expense for the quarter ending 2025-12-31 was -$159.00.
- Nexalin Technology, Inc. interest expense for the quarter ending 2025-09-30 was -$2.29K.
- Nexalin Technology, Inc. interest expense for fiscal 2025 was -$8.24K.
- Nexalin Technology, Inc. interest expense for fiscal 2024 was -$3.19K, a 108.22% decline from fiscal 2023.
- Nexalin Technology, Inc. interest expense for fiscal 2023 was $38.84K, a 34.60% decline from fiscal 2022.
- Nexalin Technology, Inc. interest expense for fiscal 2022 was $59.38K, a 27.86% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$129.00 10-Q · filed 2026-08-12 | -$163.00 10-Q · filed 2026-08-12 | -$322.00 derived: sum of 3 quarters · filed 2026-08-12 | -$2.61K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$34.00 10-Q · filed 2026-05-08 | -$193.00 derived: sum of 2 quarters · filed 2026-05-08 | -$2.48K derived: sum of 3 quarters · filed 2026-05-08 | -$7.17K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$159.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$2.45K derived: sum of 2 quarters · filed 2026-03-25 | -$7.14K derived: sum of 3 quarters · filed 2026-08-12 | -$8.24K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$2.29K 10-Q · filed 2025-11-14 | -$6.98K derived: sum of 2 quarters · filed 2026-08-12 | -$8.08K 10-Q · filed 2025-11-14 | -$9.90K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$4.69K 10-Q · filed 2026-08-12 | -$5.79K 10-Q · filed 2026-08-12 | -$7.62K derived: sum of 3 quarters · filed 2026-08-12 | -$8.62K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$1.10K 10-Q · filed 2026-05-08 | -$2.93K derived: sum of 2 quarters · filed 2026-05-08 | -$3.93K derived: sum of 3 quarters · filed 2026-05-08 | -$3.99K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$1.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$2.82K derived: sum of 2 quarters · filed 2026-03-25 | -$2.89K derived: sum of 3 quarters · filed 2026-03-25 | -$3.19K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$1.00K 10-Q · filed 2025-11-14 | -$1.07K derived: sum of 2 quarters · filed 2025-11-14 | -$1.37K 10-Q · filed 2025-11-14 | $17.78K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$66.00 10-Q · filed 2025-08-06 | -$370.00 10-Q · filed 2025-08-06 | $18.78K derived: sum of 3 quarters · filed 2025-09-23 | $24.11K derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-03-31 | -$304.00 10-Q · filed 2025-05-13 | $18.85K derived: sum of 2 quarters · filed 2025-09-23 | $24.18K derived: sum of 3 quarters · filed 2025-09-23 | $29.69K derived: sum of 4 quarters · filed 2025-09-23 |
| 2023-12-31 | $19.15K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | $24.48K derived: sum of 2 quarters · filed 2025-09-23 | $30.00K derived: sum of 3 quarters · filed 2025-09-23 | $38.84K 10-K/A · filed 2025-09-23 |
| 2023-09-30 | $5.33K 10-Q · filed 2024-11-08 | $10.85K derived: sum of 2 quarters · filed 2024-11-08 | $19.68K 10-Q · filed 2024-11-08 | $33.18K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $5.52K 10-Q · filed 2024-08-08 | $14.36K 10-Q · filed 2024-08-08 | $27.85K derived: sum of 3 quarters · filed 2024-08-08 | $38.30K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $8.84K 10-Q · filed 2024-05-10 | $22.33K derived: sum of 2 quarters · filed 2024-05-10 | $32.78K derived: sum of 3 quarters · filed 2024-05-10 | |
| 2022-12-31 | $13.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $23.95K derived: sum of 2 quarters · filed 2024-03-27 | $59.38K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $10.45K 10-Q · filed 2022-11-10 | $45.89K 10-Q · filed 2022-11-10 | ||
| 2022-03-31 | $18.13K 10-Q · filed 2023-05-10 | $36.57K derived: sum of 2 quarters · filed 2023-05-10 | $63.75K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | $18.44K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $45.61K derived: sum of 2 quarters · filed 2023-03-27 | $82.32K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $27.18K 10-Q · filed 2022-11-10 | $63.88K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |